YARROW BIOSCIENCE, INC. Operating Cash Flow
YARROW BIOSCIENCE, INC. (YARW) reported Operating Cash Flow of -$6.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.99M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.08M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$10.80M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$11.46M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$25.34M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$29.20M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$56.37M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$137.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.99M derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$6.07M 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$4.08M S-4/A · filed 2026-06-03 | |||||||
| 2025-12-31 | -$33.12M S-4/A · filed 2026-06-03 | |||||||
| 2025-06-30 | -$10.80M derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$22.26M 10-Q · filed 2026-08-13 | -$31.26M derived: sum of 3 quarters · filed 2026-08-13 | -$39.77M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$11.46M S-4/A · filed 2026-06-03 | -$20.46M derived: sum of 2 quarters · filed 2026-06-03 | -$28.97M derived: sum of 3 quarters · filed 2026-06-03 | -$37.45M derived: sum of 4 quarters · filed 2026-06-03 | ||||
| 2024-12-31 | -$9.00M derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | -$17.51M derived: sum of 2 quarters · filed 2026-06-03 | -$25.99M derived: sum of 3 quarters · filed 2026-06-03 | -$33.97M S-4/A · filed 2026-06-03 | ||||
| 2024-09-30 | -$8.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$16.99M derived: sum of 2 quarters · filed 2025-08-14 | -$24.97M 10-Q · filed 2024-11-07 | -$30.11M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | -$8.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$16.46M 10-Q · filed 2025-08-14 | -$21.60M derived: sum of 3 quarters · filed 2025-08-14 | -$26.75M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$7.98M 10-Q · filed 2025-05-08 | -$7.98M 10-Q · filed 2024-05-09 | -$13.12M derived: sum of 2 quarters · filed 2025-05-08 | -$18.27M derived: sum of 3 quarters · filed 2025-05-08 | -$27.84M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$10.29M derived: sum of 2 quarters · filed 2025-03-06 | -$19.86M derived: sum of 3 quarters · filed 2025-03-06 | -$25.34M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | -$5.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$14.73M derived: sum of 2 quarters · filed 2024-11-07 | -$20.20M 10-Q · filed 2024-11-07 | -$25.02M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$9.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$15.05M 10-Q · filed 2024-08-14 | -$19.86M derived: sum of 3 quarters · filed 2024-08-14 | -$26.99M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$5.48M 10-Q · filed 2024-05-09 | -$10.29M derived: sum of 2 quarters · filed 2024-05-09 | -$17.41M derived: sum of 3 quarters · filed 2024-05-09 | -$25.64M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$11.94M derived: sum of 2 quarters · filed 2024-03-01 | -$20.16M derived: sum of 3 quarters · filed 2024-03-01 | -$29.20M 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | -$7.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$15.35M derived: sum of 2 quarters · filed 2023-11-13 | -$24.39M 10-Q · filed 2023-11-13 | -$25.32M 10-Q · filed 2022-11-14 | -$34.41M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$8.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$17.26M 10-Q · filed 2023-08-14 | -$18.20M 10-Q · filed 2022-08-12 | -$27.28M derived: sum of 3 quarters · filed 2023-08-14 | -$44.82M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$9.04M 10-Q · filed 2023-05-11 | -$9.97M 10-Q · filed 2022-05-12 | -$19.06M derived: sum of 2 quarters · filed 2023-05-11 | -$36.60M derived: sum of 3 quarters · filed 2023-05-11 | -$52.85M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$27.56M derived: sum of 2 quarters · filed 2023-03-14 | -$43.82M derived: sum of 3 quarters · filed 2023-03-14 | -$56.37M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$17.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$33.80M derived: sum of 2 quarters · filed 2022-11-14 | -$46.35M 10-Q · filed 2022-11-14 | -$71.72M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$16.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$28.81M 10-Q · filed 2022-08-12 | -$54.18M derived: sum of 3 quarters · filed 2022-08-12 | -$77.82M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$12.55M 10-Q · filed 2022-05-12 | -$37.93M derived: sum of 2 quarters · filed 2022-05-12 | -$61.56M derived: sum of 3 quarters · filed 2022-05-12 | -$97.42M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$25.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$49.01M derived: sum of 2 quarters · filed 2022-03-17 | -$84.87M derived: sum of 3 quarters · filed 2022-03-17 | -$137.08M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$23.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$59.50M derived: sum of 2 quarters · filed 2021-11-10 | -$111.71M 10-Q · filed 2021-11-10 | -$133.95M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$35.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$88.07M 10-Q · filed 2021-08-12 | -$110.32M derived: sum of 3 quarters · filed 2021-08-12 | -$132.10M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$52.21M 10-Q · filed 2021-05-06 | -$74.46M derived: sum of 2 quarters · filed 2021-05-06 | -$96.24M derived: sum of 3 quarters · filed 2021-05-06 | -$108.96M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$22.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$44.03M derived: sum of 2 quarters · filed 2021-03-04 | -$56.75M derived: sum of 3 quarters · filed 2021-03-04 | -$73.39M 10-K · filed 2021-03-04 | -$65.10M 10-K · filed 2020-03-03 | |||
| 2019-09-30 | -$21.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$34.51M derived: sum of 2 quarters · filed 2020-11-05 | -$51.15M 10-Q · filed 2020-11-05 | -$48.69M 10-Q · filed 2019-10-31 | -$83.70M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2019-06-30 | -$12.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$29.36M 10-Q · filed 2020-08-06 | -$32.31M 10-Q · filed 2019-08-01 | -$61.91M derived: sum of 3 quarters · filed 2021-03-04 | -$74.08M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2019-03-31 | -$16.64M 10-Q · filed 2020-05-11 | -$18.06M 10-Q · filed 2019-05-02 | -$49.19M derived: sum of 2 quarters · filed 2021-03-04 | -$61.36M derived: sum of 3 quarters · filed 2021-03-04 | -$74.10M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2018-12-31 | -$32.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$44.72M derived: sum of 2 quarters · filed 2021-03-04 | -$57.46M derived: sum of 3 quarters · filed 2021-03-04 | -$68.66M 10-K · filed 2021-03-04 | -$52.73M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | -$12.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$24.91M derived: sum of 2 quarters · filed 2019-10-31 | -$36.12M 10-Q · filed 2019-10-31 | -$46.27M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | -$12.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$23.94M 10-Q · filed 2019-08-01 | -$34.10M derived: sum of 3 quarters · filed 2020-03-03 | -$46.62M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | -$11.20M 10-Q · filed 2019-05-02 | -$11.29M 10-Q · filed 2018-05-09 | -$21.36M derived: sum of 2 quarters · filed 2020-03-03 | -$33.88M derived: sum of 3 quarters · filed 2020-03-03 | -$33.84M derived: sum of 4 quarters · filed 2020-03-03 | |||
| 2017-12-31 | -$10.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$22.68M derived: sum of 2 quarters · filed 2020-03-03 | -$22.64M derived: sum of 3 quarters · filed 2020-03-03 | -$28.22M 10-K · filed 2020-03-03 | -$28.25M 10-K · filed 2018-03-28 | |||
| 2017-09-30 | -$12.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$12.48M derived: sum of 2 quarters · filed 2018-11-07 | -$18.07M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$5.55M 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | -$5.58M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | -$2.27M 10-K · filed 2019-02-28 | -$2.29M 10-K · filed 2018-03-28 | ||||||
| 2015-12-31 | -$4.18M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |